3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
21
Liver Neoplasms
4
Recurrence
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Sarcoma
1
Recurrence Hepatocellular Carcinoma
1
Pleural Neoplasms
1
Pancreatic Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Recurrence, Local
1
Mediastinal Neoplasms
1
Malignant Neoplasm in the Head and Neck
1
Lung Neoplasms
1
Lung Metastases
1
Liver Cirrhosis
1
Hypoxia
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Ultrasonography
2
Tomography, X-Ray Computed
2
tremelimumab
1
lenvatinib
1
hepatitis C immune globulin, human
1
fluoromisonidazole
1
epigallocatechin gallate
1
durvalumab
1
babao dan
1
Vitamin B 6
1
Urination
1
Tomography
1
Tidal Volume
1
Rosuvastatin Calcium
1
Propranolol
1
Probiotics
1
Preoperative Exercise
1
Positron-Emission Tomography
1
Portasystemic Shunt, Transjugular Intrahepatic
1
Population Groups
1
Plasmapheresis
1
Oxaliplatin
1
Nadolol
1
Mebendazole
1
Introns
1
Immunoglobulin G
1
Glutathione
1
Gemcitabine
1
Furosemide
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Cirrhosis
×
Ethiodized Oil
×
Clear all
NCT00470340
2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
263 enrolled